Article Details
Retrieved on: 2025-03-17 17:19:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has agreed to acquire EsoBiotec, a biotechnology firm specializing in in vivo cell therapies. The acquisition includes EsoBiotec's ...
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here